RECRUITING

Breast Cancer Survivorship Biorepository

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study collects blood samples as well as clinical and self-report data from stage I-III breast cancer survivors to create a biorepository for future use. The creation of this biorepository will allow for future research into links between individual, molecular, and genomic signatures and cancer outcomes.

Official Title

A Comprehensive Breast Cancer Survivorship Biorepository

Quick Facts

Study Start:2022-04-11
Study Completion:2028-04-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05786664

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Women of all racial and ethnic groups 18 years of age or older
  2. * Women with a diagnosis of invasive breast cancer (stages I-III) within the past 7 years
  3. * Women who have completed active treatment for breast cancer (surgery, chemotherapy, HER2-directed therapy and radiation)
  4. * Prior participation on clinical trials is allowed
  1. * Current receipt of interventional clinical trial participation
  2. * Stage IV (metastatic) cancer
  3. * Prior history of recurrence (except recurrence following ductal carcinoma in situ)
  4. * Inability to give informed consent
  5. * Unable to speak English, Spanish, Chinese, or Korean

Contacts and Locations

Study Contact

Audrey Saghian, MPH
CONTACT
323-865-6086
amsaghia@usc.edu

Principal Investigator

Bodour Salhia, PhD
PRINCIPAL_INVESTIGATOR
University of Southern California

Study Locations (Sites)

USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033
United States

Collaborators and Investigators

Sponsor: University of Southern California

  • Bodour Salhia, PhD, PRINCIPAL_INVESTIGATOR, University of Southern California

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-04-11
Study Completion Date2028-04-11

Study Record Updates

Study Start Date2022-04-11
Study Completion Date2028-04-11

Terms related to this study

Additional Relevant MeSH Terms

  • Anatomic Stage I Breast Cancer AJCC v8
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • Invasive Breast Carcinoma